TEICOPLANIN Labatec subst sèche 200 mg flac
7680597650012
CH-59765
J01XA02
08.01.9.
1 / 3
google
Details
- Product number
- 5976501
- CPT
- -
- Packaging group
- 1 x 200
- Unit
- mg
- Composition
- Praeparatio cryodesiccata: teicoplaninum 200 mg, natrii chloridum corresp. natrium 9.44 mg, pro vitro.
Articles (1)
Teicoplanin Labatec 200 mg, poudre pour solution injectable/pour perfusion
Puder
1 x 200
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
9.44 MG | Substance | HBESI |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 59765
- Drug name
- Teicoplanin Labatec, poudre pour solution injectable/pour perfusion
- Galenic form
- PULPA
- ATC Code
- J01XA02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 03/02/2010
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.9.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TEICOPLANIN Labatec subst sèche 200 mg flac
- Description (DE)
- TEICOPLANIN Labatec Trockensub 200 mg Durchstf
- Market launch
- 03/02/2010
- Narcotic (BTM)
- No